IL-33 anticorps (N-Term)
Aperçu rapide pour IL-33 anticorps (N-Term) (ABIN632244)
Antigène
Voir toutes IL-33 (IL33) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- IL33 antibody was raised against the N terminal of IL33
-
Purification
- Affinity purified
-
Immunogène
- IL33 antibody was raised using the N terminal of IL33 corresponding to a region with amino acids AKEVCPMYFMKLRSGLMIKKEACYFRRETTKRPSLKTGRKHKRHLVLAAC
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
IL33 Blocking Peptide, , is also available for use as a blocking control in assays to test for specificity of this IL33 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of IL33 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- IL-33 (IL33) (Interleukin 33 (IL33))
-
Autre désignation
- IL33
-
Sujet
- Cytokine that binds to and signals through IL1RL1/ST2 and its stimulation recruits MYD88, IRAK1, IRAK4, and TRAF6, followed by phosphorylation of MAPK3/ERK1 and/or MAPK1/ERK2, MAPK14, and MAPK8. IL33 induces T helper type 2-associated cytokines.
-
Poids moléculaire
- 31 kDa (MW of target protein)
-
Pathways
- Production of Molecular Mediator of Immune Response
Antigène
-